The Network for Multidisciplinary Studies on ARV-Based HIV Prevention (NEMUS) hosted a webinar on PrEP for Transwomen: what are the opportunities and challenges led by JoAnne Keatley and Dr. Madeline Deutsch.
Avac Event
PrEP for Trans Women: What are the Opportunities and Challenges?
Avac Event
Transgender Women and PrEP: What’s the latest?
The US Women and PrEP Working Group and partners had a first-hand look at PrEP and transgender women — through the eyes of women prescribing it, using it, choosing not to use it, advocates calling for more research on it and policy-makers charged with integrating it into the national HIV response.
You can click here to view the video.
Slides are also available here.
Avac Event
EATG Webinar 2: Pre-Exposure Prophylaxis
This series of three webinars, hosted jointly by EATG and AVAC, is designed to prepare and update EATG members for a special meeting on new developments in prevention on 23-25th January 2015 in Brussels. The second webinar covered pre-exposure prophylaxis (PrEP). The third webinar covered vaccines and microbicides on the 12th December.
Avac Event
NY PrEP Update – What You Need To Know in 2015
Heard about PrEP & Truvada? Not sure if it’s right for you? Not sure how to get it with or without insurance? Let’s clear up some rumors and get the facts! Our panel of experts brought people up to speed on the latest information, facts, controversies, and answered burning questions.
Avac Event
Women and HIV Prevention Research: Designing, testing and marketing products to improve adherence
The fourth webinar in AVAC’s Research & Reality series, a year-long dialogue about prevention research and advocacy, this call provided a forum to learn about and discuss key issues around women and the HIV prevention agenda, including challenges around marketing of and adherence to new prevention options.
View the full webinar here.
Avac Event
Unpacking the New CDC Guidelines on PrEP for HIV Prevention
On May 14, the US Centers for Disease Control (CDC) and the US Public Health Service released new clinical guidelines on using daily oral TDF/FTC (also known as Truvada) as PrEP for HIV prevention. This type of guideline is used by the US government to set national norms for health providers. It is the first such national guideline issued anywhere for PrEP use. Representatives from the CDC provided an overview of the guidelines and answer questions about their content and implications. This was followed by a moderated discussion.
Watch the full webinar here.
Avac Event
Pleasure, Protection, Love, Lust, And Listening to Communities: The Future of HIV Prevention is Here
A webinar in memory of HIV prevention pioneer and revolutionary Jeff McConnell. A respected and passionate sociologist, Jeff (who passed away at the age of 49 this past February) was also a gay man living with HIV, and his identity was an important component of the science he conducted. His brilliant, human-touch research on gay men’s sex, sexuality, and various prevention methodologies involving treatment and PrEP was groundbreaking, visionary, and way ahead of most of us.
Influential on a global scale, Jeff’s work has given us powerful insight into social and sexual networks – and love and pleasure – as important, necessary components of HIV prevention efforts. Panelists paid tribute and memorialized Jeff by reminding us of his pivotal contributions to science and sharing anecdotes.
They also discussed where we are today and the future of HIV prevention.
Watch the full flash webinar here.
Avac Event
What are the HIV prevention needs of people who use drugs in Eastern Europe?
Hosted jointly by NAM and AVAC, the second webinar in the 2014 series covered harm reduction, pre-exposure prophylaxis (PrEP) and Hepatitis C prevention in people who use drugs, with news from relevant studies and new initiatives in Europe.
Avac Event
PrEP @ 2 years—and still counting women in…
The US Women & PrEP Working Group, SisterLove and AVAC hosted a webinar marking the two-year anniversary of the FDA licensing of Truvada as PrEP in the US.
This webinar provided an opportunity to share updates and resources in the field and discussed how far we’ve moved in getting women involved in the rollout of PrEP. The webinar reviewed what we know and don’t know about women’s motivations and barriers to consider daily oral PrEP as an intervention. Speakers included Karen Hoover from the US CDC, Judy Auerbach from the University of California at San Francisco, Alan McCord from Project Inform, and moderator, Dazon Dixon Diallo of SisterLove and the US Women & PrEP Working Group.
Avac Event
Results of the iPrEx open-label extension (iPrEx OLE): PrEP uptake, sexual practices and HIV incidence
Get details on the iPrEx OLE study from principal investigator Robert Grant, who presented the data at AIDS 2014. The first open-label PrEP study to publish results, these data from iPrEx OLE begin to answer a number of questions on PrEP use in the “real world”.